Magellan Health (MGLN) Tops Q2 EPS by 14c

Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.09 billion.

Magellan Health sees FY2015 EPS of $1.69-$2.28, versus the consensus of $2.04.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M